Tyrosine kinase receptor 3D structures
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 48: | Line 48: | ||
**[[2xb7]], [[2xba]], [[3aox]], [[4ccb]], [[4ccu]], [[4cli]], [[4cmo]], [[4cmt]], [[4cmu]], [[4cnh]], [[4ctb]], [[4ctc]], [[5imx]], [[5kz0]], [[6edl]], [[6ebw]], [[6e0r]], [[6mx8]], [[7btt]], [[7jy4]], [[7jyr]], [[7jys]], [[7jyt]], [[8arj]] - hAlk kinase domain + inhibitor<br /> | **[[2xb7]], [[2xba]], [[3aox]], [[4ccb]], [[4ccu]], [[4cli]], [[4cmo]], [[4cmt]], [[4cmu]], [[4cnh]], [[4ctb]], [[4ctc]], [[5imx]], [[5kz0]], [[6edl]], [[6ebw]], [[6e0r]], [[6mx8]], [[7btt]], [[7jy4]], [[7jyr]], [[7jys]], [[7jyt]], [[8arj]] - hAlk kinase domain + inhibitor<br /> | ||
**[[4dce]], [[4fob]], [[4foc]], [[4fod]], [[4fny]], [[4fnz]], [[4joa]], [[4mkc]], [[4z55]], [[5iug]], [[5iuh]], [[5iui]], [[4cd0]], [[4clj]] - hAlk kinase domain (mutant) + inhibitor<br /> | **[[4dce]], [[4fob]], [[4foc]], [[4fod]], [[4fny]], [[4fnz]], [[4joa]], [[4mkc]], [[4z55]], [[5iug]], [[5iuh]], [[5iui]], [[4cd0]], [[4clj]] - hAlk kinase domain (mutant) + inhibitor<br /> | ||
| - | **[[2xp2]], [[ | + | **[[2xp2]], [[6mx8]], [[5fto]], [[5ftq]], [[7r7k]], [[7r7r]] - hAlk kinase domain + cancer drug<br /> |
**[[2yfx]], [[4anq]], [[4ans]], [[5aaa]], [[5aab]], [[5aac]], [[5a9u]], [[5aa8]], [[5aa9]] - hAlk kinase domain (mutant) + cancer drug<br /> | **[[2yfx]], [[4anq]], [[4ans]], [[5aaa]], [[5aab]], [[5aac]], [[5a9u]], [[5aa8]], [[5aa9]] - hAlk kinase domain (mutant) + cancer drug<br /> | ||
**[[7n00]], [[7nwz]]] - hAlk kinase domain (mutant) + AUG-alpha<br /> | **[[7n00]], [[7nwz]]] - hAlk kinase domain (mutant) + AUG-alpha<br /> | ||
**[[7ls0]] - hAlk kinase domain/AUG-alpha<br /> | **[[7ls0]] - hAlk kinase domain/AUG-alpha<br /> | ||
| - | * | + | *RET tyrosine kinase receptor or proto-oncogene tyrosine protein kinase receptor Ret |
**[[6nja]] - hTK Ret kinase domain<br /> | **[[6nja]] - hTK Ret kinase domain<br /> | ||
Current revision
Updated on 21-August-2024
